Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.004 AUD | 0.00% | 0.00% | +14.29% |
03-25 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
03-14 | Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+14.29% | 8.29M | |
+24.04% | 48.09B | |
+47.30% | 40.62B | |
-2.67% | 40.43B | |
-6.95% | 28.36B | |
+7.55% | 24.89B | |
-19.79% | 19.01B | |
+28.86% | 12.09B | |
-0.64% | 11.88B | |
-0.29% | 11.8B |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited
- Avecho Biotechnology Signs Development Deal for TPM-enhanced Ibuprofen Gel for US market; Shares Up 10%